ABSTRACT
BACKGROUND: We aimed to compare patient characteristics and outcome of patients who had either undergone pulmonary vein isolation (PVI) or AV-node ablation (AVN) to control AF-related symptoms. METHODS: From the German Ablation Registry, we analyzed data of 4444 patients (95%) who had undergone PVI and 234 patients (5%) with AVN. RESULTS: AVN patients were on average 10 years older than PVI patients (71 ± 10 vs. 61 ± 10 years, p < 0.001) with 33% aged > 75 years. AVN patients had significantly more cardiovascular comorbidities (diabetes 21% vs. 8%, renal insufficiency 24% vs. 3%, underlying heart disease 80% vs. 36%, severely reduced left ventricular function 28% vs. 1%, all p < 0.001). Significantly more PVI patients had paroxysmal AF (63% vs. 18%, p < 0.001), and more AVN patients had long-standing persistent AF (44% vs. 7%, p < 0.001). At 1-year follow-up, mortality in the AVN group was much higher (Kaplan-Meier estimates 9.8% vs. 0.5%). 20% of PVI patients had undergone another ablation vs. 3% AVN patients (p < 0.001). Symptomatic improvement was equally achieved in about 80%. Re-hospitalization for cardiovascular reasons occurred significantly more often in PVI vs. AVN patients (31% vs. 18%, p < 0.001). CONCLUSION: In the large German Ablation Registry, AVN ablation was performed much less frequently than PVI for symptomatic treatment of AF and typically in older patients with more comorbidity. Symptomatic improvement was similar in both groups. Hospitalizations for cardiovascular reasons were lower in AVN patients despite older age and more cardiovascular comorbidities. 20% of PVI patients had undergone at least one re-ablation.
Subject(s)
Atrial Fibrillation/surgery , Atrioventricular Node/surgery , Catheter Ablation/methods , Heart Rate/physiology , Patient Satisfaction , Pulmonary Veins/surgery , Registries , Aged , Atrial Fibrillation/mortality , Atrial Fibrillation/physiopathology , Atrioventricular Node/physiopathology , Female , Follow-Up Studies , Germany/epidemiology , Humans , Male , Middle Aged , Prospective Studies , Recurrence , Survival Rate/trends , Time Factors , Treatment OutcomeABSTRACT
BACKGROUND: Optimization of AV and VV delay programming has been shown to be essential for the success of cardiac resynchronization therapy (CRT). Acute hemodynamic improvement can be obtained by intracardiac electrocardiogram (IEGM)-based optimization. The aim of the present study was to evaluate whether this IEGM-based algorithm is comparable to the current gold standard of echocardiography. METHODS: After device implantation patients with standard criteria for CRT, AV and VV delay programming was either optimized by an IEGM-based algorithm (IEGM group, n = 24) or by echocardiography (echo group, n = 24). Cardiopulmonary exercise capacity was assessed after 3 and 12 months on the basis of NYHA class and the 6-min-walk test. Left ventricular ejection fraction was evaluated by echocardiography. RESULTS: In both groups there was a significant decrease in NYHA class and a significant increase in 6-min-walk distance and ejection fraction after 3 and 12 months. After 12 months there was no significant difference in the proportion of responders, NYHA class and 6-min-walk distance between the IEGM the echo group. CONCLUSION: The present data show that a sustained improvement of cardiopulmonary exercise capacity can be obtained by optimizing CRT patients on the basis of an IEGM algorithm. The comparable results for cardiopulmonary exercise parameters suggest that this new method might become an important tool for adjusting CRT programming in daily practice.
Subject(s)
Cardiac Resynchronization Therapy/methods , Echocardiography/methods , Electrocardiography/methods , Heart Failure/therapy , Signal Processing, Computer-Assisted , Aged , Algorithms , Bundle-Branch Block/mortality , Bundle-Branch Block/physiopathology , Bundle-Branch Block/therapy , Cardiac Resynchronization Therapy Devices , Echocardiography/instrumentation , Electrocardiography/instrumentation , Electrodes, Implanted , Equipment Design , Exercise Test , Female , Follow-Up Studies , Heart Atria/physiopathology , Heart Failure/mortality , Heart Failure/physiopathology , Heart Ventricles/physiopathology , Hemodynamics/physiology , Humans , Male , Middle Aged , Signal Processing, Computer-Assisted/instrumentation , Software , Survival Rate , Treatment OutcomeABSTRACT
BACKGROUND: Cardiac toxicity is a known side effect of chemotherapeutics such as 5-fluorouracil (5-FU) or cisplatin. Chest pain with ECG changes, arrhythmias, acute myocardial infarction (AMI), heart failure and sudden death have been described in the literature. CASE STUDY: We report the first case of AMI in a 59-year-old male patient with chronic myelocytic leukemia (CML) during chemotherapy with hydroxyurea. The patient was not affected by prior heart disease and did not reveal any classic risk factors for coronary heart disease. Because of the severe thrombocytopenia (23000/µl), no acetylsalicylic acid (ASA) or clopidogrel were given but low dose heparin (400 U/h). Urgent coronary angiography revealed complete thrombotic occlusion of the proximal left descending coronary artery. CONCLUSION: This case reveals that AMI can occur during chemotherapy with hydroxyurea in patients without prior heart disease. The pathogenesis of this phenomenon remains hitherto unclear. Coronary artery spasm, lesions of the endothelium as well as coagulation disorders have been postulated to explain this side effect of hydroxyurea.
Subject(s)
Anterior Wall Myocardial Infarction/chemically induced , Antineoplastic Agents/toxicity , Coronary Thrombosis/chemically induced , Hydroxyurea/toxicity , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Angioplasty, Balloon, Coronary , Anterior Wall Myocardial Infarction/diagnosis , Anterior Wall Myocardial Infarction/therapy , Antineoplastic Agents/therapeutic use , Aspirin/therapeutic use , Cineangiography , Combined Modality Therapy , Coronary Angiography , Coronary Thrombosis/diagnosis , Coronary Thrombosis/therapy , Dose-Response Relationship, Drug , Heparin/administration & dosage , Humans , Hydroxyurea/therapeutic use , Infusions, Intravenous , Male , Middle Aged , Platelet Aggregation Inhibitors/therapeutic use , Retreatment , Thrombocytopenia/chemically induced , Thrombocytopenia/diagnosis , Ultrasonography, InterventionalABSTRACT
BACKGROUND: Echocardiography is widely used to optimize CRT programming. A novel intracardiac electrogram method (IEGM) was recently developed as an automated programmer-based method, designed to calculate optimal atrioventricular (AV) and interventricular (VV) delays and provide optimized delay values as an alternative to standard echocardiographic assessment. OBJECTIVE: This study was aimed at determining the reliability of this new method. Furthermore the comparability of IEGM to existing echocardiographic parameters for determining optimal conduction delays was verified. METHODS: Eleven patients (age 62.9+/- 8.7; 81% male; 73% ischemic), previously implanted with a cardiac resynchronisation therapy defibrillator (CRT-D) underwent both echocardiographic and IEGM-based delay optimization. RESULTS: Applying the IEGM method, concordance of three consecutively performed measurements was found in 3 (27%) patients for AV delay and in 5 (45%) patients for VV delay. Intra-individual variation between three measurements as assessed by the IEGM technique was up to 20 ms (AV: n=6; VV: n=4). E-wave, diastolic filling time and septal-to-lateral wall motion delay emerged as significantly different between the echo and IEGM optimization techniques (p < 0.05). The final AV delay setting was significantly different between both methods (echo: 126.4 +/- 29.4 ms, IEGM: 183.6 +/- 16.3 ms; p < 0.001; correlation: R = 0.573, p = 0.066). VV delay showed significant differences for optimized delays (echo: 46.4 +/- 23.8 ms, IEGM: 10.9 +/- 7.0 ms; p <0.01; correlation: R = -0.278, p = 0.407). CONCLUSION: The automated programmer-based IEGM-based method provides a simple and safe method to perform CRT optimization. However, the reliability of this method appears to be limited. Thus, it remains difficult for the examiner to determine the optimal hemodynamic settings. Additionally, as there was no correlation between the optimal AV- and VV-delays calculated by the IEGM method and the echo optimization, the use of the IEGM method and the comparability to the echo has not been definitely clarified.
ABSTRACT
BACKGROUND: Due to potential proarrhythmic side-effects levo-alpha-Acetylmethadol (LAAM) is currently not available in EU countries as maintenance drug in the treatment of opiate addiction. However, recent studies and meta-analyses underline the clinical advantages of LAAM with respect to the reduction of heroin use. Thus a reappraisal of LAAM has been demanded. The aim of the present study was to evaluate the relative impact of LAAM on QTc-interval, as a measure of pro-arrhythmic risk, in comparison to methadone, the current standard in substitution therapy. METHODS: ECG recordings were analysed within a randomized, controlled clinical trial evaluating the efficacy and tolerability of maintenance treatment with LAAM compared with racemic methadone. Recordings were done at two points: 1) during a run-in period with all patients on methadone and 2) 24 weeks after randomisation into methadone or LAAM treatment group. These ECG recordings were analysed with respect to QTc-values and QTc-dispersion. Mean values as well as individual changes compared to baseline parameters were evaluated. QTc-intervals were classified according to CPMP-guidelines. RESULTS: Complete ECG data sets could be obtained in 53 patients (31 LAAM-group, 22 methadone-group). No clinical cardiac complications were observed in either group. After 24 weeks, patients receiving LAAM showed a significant increase in QTc-interval (0.409s +/- 0.022s versus 0.418s +/- 0.028s, p = 0.046), whereas no significant changes could be observed in patients remaining on methadone. There was no statistically significant change in QTc-dispersion in either group. More patients with borderline prolonged and prolonged QTc-intervals were observed in the LAAM than in the methadone treatment group (n = 7 vs. n = 1; p = 0.1). CONCLUSIONS: In this controlled trial LAAM induced QTc-prolongation in a higher degree than methadone. Given reports of severe arrhythmic events, careful ECG-monitoring is recommended under LAAM medication.
Subject(s)
Long QT Syndrome/chemically induced , Methadyl Acetate/adverse effects , Narcotics/adverse effects , Adult , Electrocardiography , Female , Heart Rate/drug effects , Heart Rate/physiology , Heroin Dependence/rehabilitation , Humans , Long QT Syndrome/physiopathology , Long QT Syndrome/urine , Male , Methadone/adverse effects , Methadone/therapeutic use , Methadone/urine , Methadyl Acetate/urine , Narcotics/urineABSTRACT
Every year about 100,000 persons die from sudden cardiac death (SCD) in Germany. Although many efforts have been undertaken, mortality remains high. Only 2 - 10% of patients with out-off hospital SCD can finally be discharged from hospital after resuscitation. Observational studies show that ventricular fibrillation and ventricular tachycardia are the primary arrhythmias underlying SCD. For both arrhythmias the main determinant for survival is the time between onset and termination by defibrillation. The chance of survival declines by 10% for every minute of delay. These findings prompted the concept of early defibrillation by first responders. Many studies have shown that non-medical professionals, like police men, firemen or security officers, often arrive at the patient more early than emergency medical service. Thus, "smart" automated external defibrillators (AEDs), designed to identify VT/VF and prompt the user when to deliver a shock were introduced. These devices allow lay rescuers to terminate ventricular arrhythmias before the arrival of medical professionals. By this approach the time to defibrillation could be reduced and a significant reduction in mortality could be documented in selected situation. These encouraging results initialled the installation of AED at public places like aircrafts, airports, underground stations and shopping males. Due to the success of this approach doctors are more and more confronted with questions about technical details, reliability and cost effectiveness of these devices. The present review should give an overview about the current studies and guidelines.
Subject(s)
Death, Sudden, Cardiac/prevention & control , Defibrillators , Tachycardia, Ventricular/therapy , Ventricular Fibrillation/therapy , Algorithms , Costs and Cost Analysis , Death, Sudden, Cardiac/epidemiology , Defibrillators/economics , Defibrillators/standards , Defibrillators/statistics & numerical data , Germany/epidemiology , Humans , Legislation, Medical , Tachycardia, Ventricular/mortality , Time Factors , Ventricular Fibrillation/mortalitySubject(s)
Cerebellar Diseases/etiology , Endocarditis, Bacterial/complications , Heart Valve Diseases/complications , Myocardial Infarction/etiology , Acute Disease , Adult , Cerebellar Diseases/diagnosis , Coronary Angiography , Diagnosis, Differential , Echocardiography , Electrocardiography , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/microbiology , Heart Valve Diseases/diagnosis , Heart Valve Diseases/microbiology , Humans , Magnetic Resonance Imaging , Male , Mitral Valve/microbiology , Myocardial Infarction/diagnosisABSTRACT
We report the first case of a male patient with iodine-induced hyperthyroidism and unstable angina pectoris in whom a diagnostic cardiac catheterization with gadolinium as contrast agent was chosen. The patient was hospitalized with an iodine-induced hyperthyroidism after angioplasty using an iodinated contrast agent. He presented with a continuous arrhythmia and unstable angina pectoris. A repeated cardiac catheterization using iodinated contrast agent was contraindicated. This case report shows that gadolinium is a useful alternative contrast agent for cardiac intervention in patients with iodine-induced hyperthyroidism.
Subject(s)
Cardiac Catheterization/methods , Gadolinium , Hyperthyroidism/chemically induced , Iodine/adverse effects , Contrast Media , Coronary Angiography/adverse effects , Coronary Angiography/methods , Humans , Middle AgedABSTRACT
Telemedicine is a new milestone for the health care system in the care of patients with heart disease. New technologies and the possibilities of fast data transmission have enabled this step forward. The Cardiophone offers a new telemonitoring Service Concept, which is available 24 hours a day. The patient is by the aid of the Cardiophone connected with the Medical Service Center at just the press of a button, can record and transmit an ECG and can be localized by the incorporated GPS. We report about our experiences with 363 patients over 3 years. Out of 5064 patient contacts associated with 7561 calls, 559 emergency contacts occurred. From the initial main complaints, working diagnoses were established. The final confirmed diagnoses were arrhythmias (27.8%), coronary heart disease (25.9%), psychovegetative syndrome (12.7%), backbone pain (6.2%), gastrointestinal syndrome (3.6%), others (1.8%), and exclusion diagnosis (19.9%). Ten myocardial infarctions were diagnosed, of whom 3 were confirmed; the other 7 were treated as stabile angina pectoris. Overall 823 ECG were transmitted, in average 1.6 ECGs per emergency contact. In 131 ECGs changes of the ST-segment or T-wave could be documented; 26 patients showed a pacemaker ECG. Atrial and ventricular arrhythmias as well as conduction disturbances were seen. The majority of emergency contacts (n=477, 85.3%) were successfully managed by the Service Center. In 38 emergency contacts (6.8%) admission to hospital was recommended; in 4 cases (0.7%) an ambulance was activated via the local dispatcher by the Service Center and in 29 cases (5.2%) the emergency ambulance.
Subject(s)
Cell Phone , Electrocardiography, Ambulatory/instrumentation , Electrocardiography, Ambulatory/methods , Emergency Medicine/instrumentation , Heart Diseases/diagnosis , Telemedicine/instrumentation , Telemedicine/methods , Adolescent , Adult , Aged , Aged, 80 and over , Diagnosis, Computer-Assisted/instrumentation , Diagnosis, Computer-Assisted/methods , Emergency Medical Services/methods , Emergency Medicine/methods , Equipment Design , Equipment Failure Analysis , Female , Humans , Male , Middle Aged , User-Computer InterfaceABSTRACT
Human immunodeficiency virus (HIV) and acute immunodeficiency syndrome are known to be associated with cardiac involvement. In this respect, a relation between HIV and dilated cardiomyopathy has been described. Additionally, highly active antiretroviral therapy (HAART) may independently contribute to cardiac impairment. We here report two cases of severely reduced left ventricular function detected in the context of a recent standardized screening of 132 HIV+ individuals of the German heart failure network. Both patients presented in a poor overall condition and progressive exercise-induced dyspnea accompanied by edema or angina pectoris, respectively. Subsequent examinations revealed left bundle-branch blockade, ventricular arrhythmia, elevated serum BNP-levels as well as pathologic transthoracic echocardiography, left ventricular angiography, electron beam tomography and cardiac magnetic resonance imaging without significant coronary stenoses or immunohistological signs of an ongoing or prior myocarditis. Clinical signs of progressive chronic heart failure developed slowly but constantly following initiation of the HAART regimen. Patients were treated by an implantation of a biventricular implantable cardioverter defibrillator beside conventional conservative standard therapy followed by a significant improvement of clinical symptoms. Antiviral medication could be maintained in both patients. Taking all data into account, the diagnosis of a HAART-associated dilated cardiomyopathy could be assessed. Even though the pathogenesis of secondary heart failure after HAART is still object of investigation a mitochondrial impairment by antiviral drugs is thought to contribute the development of dilated cardiomyopathy. However, due to the coexistence of an eminent HIV infection, a direct effect of the HI virus itself can not be completely excluded.
Subject(s)
Antiretroviral Therapy, Highly Active/adverse effects , Cardiomyopathy, Dilated/chemically induced , HIV Seropositivity/drug therapy , Ventricular Function, Left/drug effects , Humans , Magnetic Resonance Imaging , Male , Middle AgedABSTRACT
AIMS: Eosinophilic heart syndromes are rare in Western countries and include endocarditis parietalis fibroplastica (EPF) and hypersensitivity myocarditis (HM). There are striking differences in natural history and morphological findings. Since diagnosis can be difficult when analysing small myocardial biopsies lacking the characteristic histological features, we studied a set of immunohistochemical markers in order to characterize the activation status of the infiltrating eosinophils to distinguish between these two entities. METHODS AND RESULTS: This study is based on the investigation of seven explanted hearts and one left ventricular specimen collected during implantation of a left ventricular assist device from a total of seven patients with HM. Also investigated were three right and three left ventricular specimens from five patients with EPF. We used antibodies (Ab) against EG1, and EG2, CD44, and CD69 which have been described as markers to distinguish between resting and activated eosinophils. The EG1 to EG2 ratio of eosinophils and the immunoreactivity against CD44 showed no differences between the two entities. However, eosinophils in the EPF were completely negative for CD69, whereas eosinophils reacted positively within the HM group. CONCLUSION: The immunohistochemical investigation of eosinophilic heart diseases using antibodies against CD69 can be a useful tool to distinguish between hypersensitivity myocarditis and endocarditis parietalis fibroplastica.
Subject(s)
Eosinophils/immunology , Heart Diseases/immunology , Immunohistochemistry , Aged , Animals , Antibodies, Monoclonal/immunology , Antigens, CD/immunology , Antigens, Differentiation, T-Lymphocyte/immunology , Diagnosis, Differential , Endocarditis/diagnosis , Endocarditis/immunology , Endocarditis/pathology , Eosinophils/pathology , Female , Heart Diseases/diagnosis , Heart Diseases/pathology , Humans , Lectins, C-Type , Male , Mice , Middle Aged , Myocarditis/diagnosis , Myocarditis/immunology , Myocarditis/pathologyABSTRACT
BACKGROUND: Stents have been introduced clinically to help maintaining the patency of the vascular lumen after balloon angioplasty. To ensure a sufficient lumen of the stented vessel, oversized stents are frequently used. However especially deployment of oversized stents may lead to mechanical injury of the intima and media of the vessel wall. The aim of the study was to characterize the vascular lesions and repair processes within the first 4 weeks after implantation of oversized stents in the rabbit carotid artery and thereby contribute to the understanding of vascular remodeling during stent implantation. METHODS: Oversized stents were implanted in the carotid artery of Chinchilla rabbits. Rabbits were sacrificed 3, 7, 14, and 28 days after stent implantation and a detailed histologic and immunohistochemical analysis was performed. RESULTS: The carotid artery was expanded by a factor of 1.3-1.5, leading to a constant dilatation of the vessel. The struts were deeply impressed in the vessel wall, resulting in a disruption of the intima, thrombus formation, media compression and segmental media necrosis. The necrotic media was repopulated by smooth muscle cells by day 7. In contrast to the intima lesions, necrotic areas of the media were not invaded by an inflammatory infiltrate. Formation of neointima, characterized by a confluent layer of endothelial cells and deposition collagenfibers started in close vicinity of the struts. CONCLUSIONS: Being part of a high-pressure system, the arterial vessel apparently adapts to constant dilatation. Deployment of oversized stents caused intima disruption, media necrosis of varying degree and constant dilatation of the vessel wall. Necrosis and repopulation of smooth muscle cells of the media took place within the first 4 weeks, leading to the speculation whether the repopulating SMC are more resistant to the constant pressure.
Subject(s)
Blood Vessel Prosthesis/adverse effects , Carotid Arteries/pathology , Carotid Arteries/surgery , Carotid Artery Injuries/etiology , Carotid Artery Injuries/pathology , Prosthesis Failure , Stents/adverse effects , Animals , Chinchilla , Equipment Failure Analysis/methods , Female , Male , Necrosis , Rabbits , Treatment OutcomeABSTRACT
Cardiomyopathy is often seen in patients with a long history of acromegaly. In order to screen for perfusion abnormalities, patients with active acromegaly without evidence for coronary heart disease were examined by single photon emission computed tomography (SPECT). The study included a group of 11 strictly selected patients with active acromegaly (7 males and 4 females; age 51 +/- 12 y [mean +/- S.D.]) with elevated age-adjusted IGF-I levels (IGF-I 569 +/- 193 micro g/l; GH 31.2 +/- 56.3 micro g/l) compared to an age- and sex-matched non-acromegalic control group with comparable muscle mass index of the left ventricle (126 +/- 41 active vs. 122 +/- 33 g/m 2 control group) and body mass index (26.6 +/- 2.7 vs. 27.0 +/- 5.0 kg/m 2). To address this issue, myocardial perfusion was investigated by single photon emission computed tomography (SPECT) using a triple head gamma-camera. 70 MBq 201TlCl was injected, and post-stress (from bicycle ergometer) images were obtained. Images were interpreted quantitatively by bull's eye polary map (16 regions of the left ventricle) and were compared to the control group. In the patients with active acromegaly, the mean nuclide uptake of the 16 regions of the left ventricle after bicycle stress examination was lower than in the control group (82.99 +/- 2.85 active vs 85.48 +/- 1.29 control group, p < 0.01). Non-homogeneity of nuclide uptake was defined as the standard deviations of the 16 regions and was higher in patients with active acromegaly (11.11 +/- 2.35 active vs. 8.77 +/- 1.39 control group, p < 0.01). In conclusion, myocardial perfusion is impaired in patients with active acromegaly, thus representing an early stage of cardiac involvement in acromegaly that may be directly mediated by growth hormone excess.
Subject(s)
Acromegaly/physiopathology , Heart/physiopathology , Acromegaly/pathology , Adult , Aged , Blood Flow Velocity , Blood Glucose/analysis , Body Mass Index , Brachial Artery/pathology , Brachial Artery/physiopathology , Echocardiography , Electrocardiography , Exercise Test , Fasting , Female , Heart Ventricles/pathology , Hemodynamics , Homeostasis , Human Growth Hormone/blood , Humans , Insulin Resistance , Insulin-Like Growth Factor I/analysis , Male , Middle Aged , Myocardium , Tomography, Emission-Computed, Single-PhotonSubject(s)
Arthroscopy/methods , Catheter Ablation , Radiosurgery , Cartilage, Articular/surgery , Humans , Joint Capsule/surgeryABSTRACT
A 25-year-old male student complained about episodic palpitations, dizziness, nausea and headache 5 years prior to presentation. No otorhinolaryngic, neurologic or gastrointestinal causes were identified. Several ECG recordings revealed sinus node dysfunction with intermittent sinus arrest and AV-nodal escape rhythm. The patient was given a permanent DDD-pacemaker. Six months later, the clinical symptoms were unchanged. During an attack, physical examination revealed paleness, diffuse sweating and an arterial blood pressure of 250/130 mmHg, which decreased to 120/80 mmHg within a few minutes. Abdominal ultrasound and abdominal computed tomographic scan demonstrated the presence of a large (6.4 x 5.5 cm) left-sided adrenal mass. Two 24-h-urinary collections demonstrated elevated noradrenaline (mean 315 micrograms/24 h, normal < 80 micrograms/24 h) and adrenaline (mean 268 micrograms/24 h, normal < 20 mg/24 h) levels. Blood samples, which were drawn during excessive blood pressure rise, revealed elevation of plasma catecholamines (6.793 pg/ml for adrenaline (normal 50-150 pg/ml) and 10.424 pg/ml for noradrenaline (normal 200-500 pg/ml), so that the diagnosis of pheochromocytoma was considered established. The tumor was successfully removed during laparascopic surgery. After surgery, the patient remained well and normotensive. Three months later, several long-term ECG recordings showed sinus arrhythmia with no evidence of sinus arrest or AV-nodal escape rhythm, so that the DDD pacemaker was turned off. This case underlines that sinus node dysfunction with intermittent sinus arrest and AV-nodal escape rhythm is a potential early manifestation of a pheochromocytoma. These changes seem to disappear after successful removal of the tumor.
Subject(s)
Adrenal Gland Neoplasms/diagnosis , Arrhythmias, Cardiac/etiology , Pacemaker, Artificial , Pheochromocytoma/diagnosis , Adrenal Gland Neoplasms/complications , Adrenal Gland Neoplasms/diagnostic imaging , Adrenal Gland Neoplasms/surgery , Adult , Arrhythmia, Sinus/etiology , Arrhythmia, Sinus/therapy , Arrhythmias, Cardiac/therapy , Electrocardiography , Follow-Up Studies , Humans , Laparoscopy , Male , Pheochromocytoma/complications , Pheochromocytoma/diagnostic imaging , Pheochromocytoma/surgery , Time Factors , Tomography, X-Ray Computed , Treatment Outcome , UltrasonographyABSTRACT
BACKGROUND: In patients with typical angina but angiographically normal coronary arteries, abnormal vasomotor function is assumed to be a major underlying cause. However, data on this issue are conflicting, and recent studies suggest that fluid dynamic abnormalities exist in these patients. The aim of the study was to evaluate whether early stages of atherosclerosis are characterized by alterations of baseline coronary hemodynamics and endothelium-independent vasomotion. Besides established intracoronary Doppler parameters, heterogeneity of perfusion was assessed and related to early signs of atherosclerosis as determined by electron-beam computed tomography (EBCT). METHODS: In 59 patients with typical angina and angiographically normal or near-normal coronary arteries, intracoronary Doppler measurements were performed in all 3 major coronary arteries. Baseline average peak velocity (bAPV) and hyperemic average peak velocity (hAPV) in response to intracoronary injection of adenosine were measured, and coronary flow velocity reserve (CFVR) was calculated. Heterogeneity was assessed as variability of bAPV, hAPV, and CFVR and was calculated as (STD/MEAN). 100. Doppler data were analyzed according to tertiles of the EBCT-derived Agatston calcium score (ie, score 0-1 [lowest tertile], 2-28 [medium tertile], and >28 [highest tertile]). RESULTS: The mean EBCT-derived Agatston calcium score was 49 +/- 107. No coronary calcium was observed in 17 (29%) patients. The mean values of bAPV, hAPV, and CFVR were not different between the calcium score tertiles. However, patients in the highest tertile had a significantly increased variability index of bAPV (29.6% +/- 11.6%) compared with patients in the lowest tertile (13.4% +/- 7.3%, P <.0001). Variability of CFVR was also increased in these patients (15.5% +/- 11.7% vs 10.5% +/- 4.0%, P =.03). CONCLUSION: These results indicate that early stages of atherosclerosis are characterized by microvascular abnormalities that do not uniformly affect the myocardium but are heterogeneous. The high variability of baseline coronary flow velocity with increasing coronary calcium suggests that in patients with early stages of atherosclerosis fluid dynamic effects may play a crucial role even in the absence of angiographically appreciable epicardial stenoses.
Subject(s)
Coronary Angiography/statistics & numerical data , Coronary Artery Disease/diagnosis , Coronary Circulation/physiology , Microvascular Angina/diagnosis , Adenosine/pharmacology , Angina Pectoris/diagnosis , Calcium , Coronary Artery Disease/blood , Coronary Circulation/drug effects , Coronary Vessels/drug effects , Coronary Vessels/physiology , Echocardiography, Doppler/statistics & numerical data , Female , Hemodynamics/physiology , Humans , Male , Microvascular Angina/blood , Middle Aged , Tomography, X-Ray Computed/statistics & numerical dataABSTRACT
OBJECTIVES: This study was designed to identify potential differences between the intravascular ultrasound (IVUS) characteristics of spontaneously ruptured and nonruptured coronary plaques. BACKGROUND: The identification of vulnerable plaques in vivo may allow targeted prevention of acute coronary events and more effective evaluation of novel therapeutic approaches. METHODS: Intravascular ultrasound was used to identify 29 ruptured plaques in arteries containing another nonruptured plaque in an adjacent segment. Intravascular ultrasound characteristics of these plaques were compared with plaques of computer-matched controls without evidence of plaque rupture. Plaque distribution was assessed by measuring the eccentricity of lumen location (inside the total vessel). Lumen cross-sectional area narrowing was calculated as [1 - (target/reference lumen area)] x 100%. A remodeling index was calculated as lesion/reference arterial area (>1.05 = compensatory enlargement, <0.95 = shrinkage). RESULTS: Among the three groups of plaques, there was no significant difference in quantitative angiographic parameters, IVUS reference dimensions and IVUS lumen cross-sectional area narrowing. There was a difference in plaque distribution; lumen location by IVUS was significantly more eccentric in ruptured than in nonruptured (p = 0.002) and control plaques (p < 0.0001). The arc of disease-free vessel wall was larger in ruptured than in control plaques (p < 0.0001). The remodeling pattern of ruptured and nonruptured plaques differed significantly from that of the control plaques (p = 0.0001 and 0.003); compensatory enlargement was found in 66%, 48%, and 17%, whereas shrinkage was found in 7%, 10% and 48%, respectively. CONCLUSIONS: Intravascular ultrasound assessment of plaque distribution and vascular remodeling may help to classify plaques with the highest probability of spontaneous rupture.
Subject(s)
Coronary Artery Disease/pathology , Ultrasonography, Interventional , Coronary Artery Disease/complications , Female , Humans , Male , Middle Aged , Rupture, SpontaneousABSTRACT
BACKGROUND: Residual reduction of relative coronary flow velocity reserve (rCVR) after successful coronary intervention has been related to microvascular impairment. However, the incidence of cardiac enzyme elevation as a surrogate marker of an underlying embolic myocardial injury in these cases has not been studied. METHODS AND RESULTS: A series of 55 consecutive patients with successful coronary stenting, periprocedural intracoronary Doppler analysis, and determination of creatine kinase (CK; upper limit of normal [ULN] for women 70 IU/L, for men 80 IU/L) and cardiac troponin T (cTnT; bedside test, threshold 0.1 ng/mL) before and 6, 12, and 24 hours after intervention were studied. Postprocedural rCVR was the only intracoronary Doppler parameter that independently correlated with cTnT (r=-0.498, P<0.001) and CK outcome (r=-0.406, P=0.002). Receiver operating characteristic analysis identified a postprocedural rCVR of 0.78 as the best discriminating value, with a sensitivity of 83.3% and 69.2% and a specificity of 79.1% and 76.2% for detection of cTnT and CK elevation, respectively. Stratified according to this cutoff value, the incidence of cTnT elevation was 52.6% in patients with (n=19) and 5.6% in patients without (n=36) a postprocedural rCVR <0.78 (P<0.001), associated with a CK elevation >1 times the ULN in 36.8% and 5.6% (P=0.005) of patients, respectively. CONCLUSIONS: Cardiac marker elevation can frequently be found after coronary procedures that are associated with a persistent reduction of rCVR, indicating procedural embolization of atherothrombotic debris with microvascular impairment and myocardial injury as a potential underlying mechanism.
Subject(s)
Coronary Circulation , Coronary Disease/metabolism , Myocardium/metabolism , Aged , Biomarkers/analysis , Coronary Angiography , Coronary Disease/physiopathology , Coronary Disease/therapy , Creatine Kinase/metabolism , Echocardiography, Doppler , Female , Humans , Male , Middle Aged , Myocardium/pathology , Prospective Studies , Stents , Troponin T/metabolismABSTRACT
The introduction of coronary stents is a milestone in interventional cardiology. Two landmark studies have shown that stainless steel stents significantly decrease the restenosis rate as compared to balloon angioplasty. This fact led to a marked increase of stent implantation since the first stent implantation by Jacques Puel in 1986. Although the concept of coronary stenting significantly improved the interventional therapy of coronary artery disease, restenosis remains a major unsolved drawback of this technique. In addition to procedure and disease related factors like implantation pressure and plaque burden, data suggest that the stent as a medical implant plays a crucial role in the process of neointima formation. Since its introduction in cardiology, more than 50 different stents of different configuration and material have been developed. Although recent publications report of promising results using biodegradable materials, almost all coronary stents commercially available at the moment are made of metallic alloys. Whereas first generation stents were made exclusively from stainless steel and only minor interest was focussed on the stent material in the manufacture of coronary stents, recent studies strongly suggest that the metallic alloy used has a direct impact on the extent of neointima formation. Thus, metallic alloys differ not only with respect to mechanical features, but also by their biocompatible properties. These two factors are of major importance in the induction of vessel wall injury, inflammatory processes and cell proliferation. In the first part, the present paper reviews the metallurgic characteristics of metallic materials, which are currently used or under investigation in the production of coronary stents. In the second part, clinical and experimental results are summarized with respect to their biocompatibility and impact on the process of restenosis formation.